US approval for Covidien's Pipeline embolisation device
This article was originally published in Clinica
Executive Summary
Pipeline, Covidien's embolisation device, has been awarded US premarket approval (PMA) for the treatment of brain aneurysms. Covidien will launch the device this quarter.